.Novartis levels a new frontier in its own collaboration along with Voyager Therapies, paying out $1...
.On the heels of an FDA being rejected for its own main rivalrous Novo Nordisk, Eli Lilly is actuall...
.Only a few months after dosing the first person in a stage 2 test for newly diagnosed glioblastoma,...
.Eli Lilly's look for excessive weight targets has actually led it to the black genome. The Big Phar...
.Arsenal Biosciences is proceeding up. The cell treatment company has added on $325 million in ammun...
.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...
.Aelis Farma's hopes of securing a fast, positive decision on a $one hundred thousand choice repayme...
.ProKidney has stopped some of a set of period 3 tests for its cell treatment for kidney disease aft...
.Vaxcyte unveiled what experts referred to as "magnificent" stage 1/2 records for its 31-valent pneu...
.Recursion has stumbled by means of a very early examination of its tech-enabled approach to drug ex...